Clinical Trials Browser

OTHER × Epstein-Barr Virus Infections × 30 days × Clear all

NCT02135042 2026-04-03

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Phase 2/3 Active not recruiting

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT06119256 2026-04-02

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Phase 1 Recruiting

Epstein-Barr Virus Infections